Ivanović-Krstić B, Cvetković-Matić D, Nikcević Dj, Kalimanovska-Ostrić D, Avramović D
Institute Cardiovascular Diseases, Clinical Centre of Serbia, Belgrade.
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):125-9.
Isolated systolic hypertension is a common disorder in the elderly carrying a high risk of stroke and cardiovascular disease. Isolated systolic hypertension is usually defined as a systolic blood pressure greater than or equal to 160 mmHg and diastolic blood pressure less than 95 mmHg. The arterial stiffening is the principal cause of increasing systolic pressure in advanced age. It is due to degeneration of the arterial wall and is associated with progressive arterial dilatation. Hypertension in elderly patients is also characterized by increase of peripheral vascular resistance. Due to the wide variability of blood pressure usually seen in old persons, the isolated systolic hypertension is not easy to recognize and final diagnosis requires a long period of observation. The ambulatory blood pressure monitoring proved to be helpful in distinguishing patients with true isolated systolic hypertension from subjects with exaggerated alarm reaction to the pressure measurement. Although the increased risk of cardiovascular and cerebrovascular mortality is well established for isolated systolic hypertension, there has been much debate whether available antihypertensive treatment can prevent or delay cardiovascular and cerebrovascular complications in this condition. During the last year several large new trials have been published, the so-called STOP-Hypertension, SHEP and MRC trials. All studies have demonstrated that the treatment of isolated systolic hypertension with diuretics or/and beta blockers (frequently used in combination) resulted in a significant reduction in the incidence of stroke and major cardiovascular events. New antihypertensive agents such as calcium channel blockers and angiotensin-converting enzyme inhibitors have also been shown to effectively lower systolic blood pressure in the elderly but the effects on long-term morbidity and mortality are still unknown.
单纯收缩期高血压是老年人的常见病症,具有较高的中风和心血管疾病风险。单纯收缩期高血压通常定义为收缩压大于或等于160 mmHg且舒张压小于95 mmHg。动脉僵硬度增加是老年人收缩压升高的主要原因。这是由于动脉壁退变,并伴有动脉逐渐扩张。老年患者的高血压还表现为外周血管阻力增加。由于老年人血压通常波动较大,单纯收缩期高血压不易识别,最终诊断需要长期观察。动态血压监测有助于将真正的单纯收缩期高血压患者与对血压测量反应过度的患者区分开来。尽管单纯收缩期高血压导致心血管和脑血管死亡风险增加已得到充分证实,但对于现有降压治疗能否预防或延缓这种情况下的心血管和脑血管并发症,仍存在诸多争议。在过去一年中,发表了几项大型新试验,即所谓的收缩期高血压治疗研究(STOP-Hypertension)、收缩期高血压老年人计划(SHEP)和医学研究委员会(MRC)试验。所有研究均表明,使用利尿剂或/和β受体阻滞剂(常联合使用)治疗单纯收缩期高血压可显著降低中风和主要心血管事件的发生率。新型降压药物如钙通道阻滞剂和血管紧张素转换酶抑制剂也已显示可有效降低老年人的收缩压,但对长期发病率和死亡率的影响仍未知。